e-learning
resources
Virtual 2020
Pre-Congress Content
COPD and the impact of comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristics of patients with homogeneous and heterogeneous emphysema
M. Bakeer (Mansoura, Egypt), . Duller (Vienna, Austria), K. Groß (Vienna, Austria), G. Funk (Vienna, Austria), A. Valipour (Vienna, Austria)
Source:
Virtual Congress 2020 – COPD and the impact of comorbidities
Session:
COPD and the impact of comorbidities
Session type:
E-poster session
Number:
2477
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bakeer (Mansoura, Egypt), . Duller (Vienna, Austria), K. Groß (Vienna, Austria), G. Funk (Vienna, Austria), A. Valipour (Vienna, Austria). Characteristics of patients with homogeneous and heterogeneous emphysema. 2477
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma
Related content which might interest you:
Options for homogeneous emphysema patients
Source: Annual Congress 2013 –PG1 Endoscopic lung volume reduction
Year: 2013
Mortality in a well-defined group of predominantly caucasian pulmonary sarcoidosis patients
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020
Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 257s
Year: 2002
Textural analysis demonstrates heterogeneous [
18
F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 52 (5) 1801138; 10.1183/13993003.01138-2018
Year: 2018
Outcomes in idiopathic pulmonary haemosiderosis in children are highly heterogeneous
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
Source: ERJ Open Res, 5 (1) 00014-2018; 10.1183/23120541.00014-2018
Year: 2019
Unilateral lung volume reduction surgery in patients with homogenous distribution of pulmonary emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 491s
Year: 2005
Evaluation of 76 patients with diffuse paranchimal lung disease
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007
Clinical characteristics of 112 patients with bronchiectasis
Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach
Year: 2010
The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Clinical spectrum and outcome of non IPF patients with a typical UIP picture
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Characteristics of the patients with sarcoidosis diagnosed by labial biopsy
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Clinical characteristics of COPD with mild bronchiectasis
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Features of non-obstructive emphysema in a population who underwent chronic disease screening
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Characteristics of pulmonary embolism in elderly patients.
Source: International Congress 2017 – Pulmonary embolism
Year: 2017
Do typical and atypical HRCT patterns make difference in prognosis of patients with IPF?
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Multicenter study of 53 cases of combined pulmonary fibrosis and emphysema, an underrecognized severe entity
Source: Eur Respir J 2004; 24: Suppl. 48, 53s
Year: 2004
The comparison of eosinophilic and non-eosinophilic stable COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept